{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:50:23Z","timestamp":1789761023916,"version":"4.0.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.sapharm.2024.01.002","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T23:16:52Z","timestamp":1704410212000},"page":"246-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Economic evaluations of telepharmacy services in non-cancer settings: A systematic review"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6708-2691","authenticated-orcid":false,"given":"Keshia R.","family":"De Guzman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Gavanescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Centaine L.","family":"Snoswell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.sapharm.2024.01.002_bib1","doi-asserted-by":"crossref","DOI":"10.2196\/15688","article-title":"Economic advantages of telehealth and virtual health practitioners: return on investment analysis","volume":"3","author":"Snoswell","year":"2020","journal-title":"JMIR Perioper Med"},{"key":"10.1016\/j.sapharm.2024.01.002_bib2","doi-asserted-by":"crossref","DOI":"10.1071\/AH22134","article-title":"Telehealth sustainability after COVID-19 - can you see me by video?","author":"De Guzman","year":"2022","journal-title":"Aust Health Rev"},{"issue":"4","key":"10.1016\/j.sapharm.2024.01.002_bib3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/1357633X20960638","article-title":"Building on the momentum: sustaining telehealth beyond COVID-19","volume":"28","author":"Thomas","year":"2022","journal-title":"J Telemed Telecare"},{"issue":"2","key":"10.1016\/j.sapharm.2024.01.002_bib4","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/0897190018791060","article-title":"Telepharmacy: a new paradigm for our profession","volume":"33","author":"Le","year":"2020","journal-title":"J Pharm Pract"},{"issue":"13","key":"10.1016\/j.sapharm.2024.01.002_bib5","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2146\/ajhp090531","article-title":"Current practices and state regulations regarding telepharmacy in rural hospitals","volume":"67","author":"Casey","year":"2010","journal-title":"Am J Health Syst Pharm"},{"issue":"4","key":"10.1016\/j.sapharm.2024.01.002_bib6","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.sapharm.2015.06.002","article-title":"Telepharmacy: time to pick up the line","volume":"13","author":"Win","year":"2017","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.sapharm.2024.01.002_bib7","article-title":"Telepharmacy: a systematic review of field application, benefits, limitations, and applicability during the COVID-19 pandemic","author":"Dat","year":"2022","journal-title":"Telemed J e Health"},{"issue":"14","key":"10.1016\/j.sapharm.2024.01.002_bib8","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/ajhp\/56.14.1405","article-title":"Telemedicine and telepharmacy: current status and future implications","volume":"56","author":"Angaran","year":"1999","journal-title":"Am J Health Syst Pharm : AJHP : official journal of the American Society of Health-System Pharmacists"},{"issue":"10","key":"10.1016\/j.sapharm.2024.01.002_bib9","doi-asserted-by":"crossref","DOI":"10.2196\/17298","article-title":"Determining if telehealth can reduce health system costs: scoping review","volume":"22","author":"Snoswell","year":"2020","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.sapharm.2024.01.002_bib10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/RMHP.S97248","article-title":"Multimorbidity in chronic disease: impact on health care resources and costs","volume":"9","author":"McPhail","year":"2016","journal-title":"Risk Manag Healthc Pol"},{"issue":"1","key":"10.1016\/j.sapharm.2024.01.002_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-019-7762-5","article-title":"Consequences of chronic diseases and other limitations associated with old age \u2013 a scoping review","volume":"19","author":"Maresova","year":"2019","journal-title":"BMC Publ Health"},{"issue":"1","key":"10.1016\/j.sapharm.2024.01.002_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12861","article-title":"Trends in age\u2010related disease burden and healthcare utilization","volume":"18","author":"Atella","year":"2019","journal-title":"Aging Cell"},{"issue":"3","key":"10.1016\/j.sapharm.2024.01.002_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/acr2.11114","article-title":"The relation of the chronic disease epidemic to the health care crisis","volume":"2","author":"Holman","year":"2020","journal-title":"ACR Open Rheumatology"},{"issue":"5","key":"10.1016\/j.sapharm.2024.01.002_bib14","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/1753-6405.12925","article-title":"The economic cost of preventable disease in Australia: a systematic review of estimates and methods","volume":"43","author":"Crosland","year":"2019","journal-title":"Aust N Z J Publ Health"},{"key":"10.1016\/j.sapharm.2024.01.002_bib15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jhealeco.2017.11.001","article-title":"Health care expenditures, age, proximity to death and morbidity: implications for an ageing population","volume":"57","author":"Howdon","year":"2018","journal-title":"J Health Econ"},{"key":"10.1016\/j.sapharm.2024.01.002_bib16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.pmedr.2018.10.008","article-title":"The global burden of multiple chronic conditions: a narrative review","volume":"12","author":"Hajat","year":"2018","journal-title":"Preventive Medicine Reports"},{"issue":"3","key":"10.1016\/j.sapharm.2024.01.002_bib17","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1377\/hlthaff.27.3.759","article-title":"The Triple aim: care, health, and cost","volume":"27","author":"Berwick","year":"2008","journal-title":"Health Aff"},{"issue":"11","key":"10.1016\/j.sapharm.2024.01.002_bib18","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/ajhp\/zxac070","article-title":"Effectiveness of telepharmacy diabetes services: a systematic review and meta-analysis","volume":"79","author":"Cao","year":"2022","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"10.1016\/j.sapharm.2024.01.002_bib19","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1353\/hpu.2021.0102","article-title":"A systematic review of the effect of telepharmacy services in the community pharmacy setting on care quality and patient safety","volume":"32","author":"Pathak","year":"2021","journal-title":"J Health Care Poor Underserved"},{"issue":"12","key":"10.1016\/j.sapharm.2024.01.002_bib20","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1177\/1060028018787213","article-title":"A systematic review of ICU and non-ICU clinical pharmacy services using telepharmacy","volume":"52","author":"Strnad","year":"2018","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.sapharm.2024.01.002_bib21","series-title":"The Cost-Effectiveness of Telepharmacy: A Systematic Review","author":"Gavanescu","year":"2022"},{"key":"10.1016\/j.sapharm.2024.01.002_bib22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jclinepi.2021.03.001","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"134","author":"Page","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.sapharm.2024.01.002_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jclinepi.2021.02.003","article-title":"Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement","volume":"134","author":"Page","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.sapharm.2024.01.002_bib24","article-title":"Telepharmacy in oncology care: a scoping review","author":"Vo","year":"2020","journal-title":"J Telemed Telecare"},{"issue":"1","key":"10.1016\/j.sapharm.2024.01.002_bib25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/1715163516680009","article-title":"Guidelines for outpatient cancer care by community pharmacists","volume":"150","author":"Broadfield","year":"2016","journal-title":"Can Pharm J\/Revue des Pharmaciens du Canada"},{"key":"10.1016\/j.sapharm.2024.01.002_bib26","unstructured":"Covidence systematic review software. Veritas Health Innovation,. www.covidence.org."},{"issue":"1","key":"10.1016\/j.sapharm.2024.01.002_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1332\/174426410X482999","article-title":"A web-based tool for adjusting costs to a specific target currency and price year","volume":"6","author":"Shemilt","year":"2010","journal-title":"Evid Policy A J Res Debate Pract"},{"issue":"1","key":"10.1016\/j.sapharm.2024.01.002_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jval.2021.10.008","article-title":"Consolidated health economic evaluation reporting standards (CHEERS) 2022 explanation and elaboration: a report of the ispor CHEERS II good practices task force","volume":"25","author":"Husereau","year":"2022","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.sapharm.2024.01.002_bib29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2146\/ajhp050177","article-title":"Telephone follow-up of patients receiving antibiotic prescriptions from community pharmacies. Article","volume":"63","author":"Beaucage","year":"2006","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2024.01.002_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jac5.1001","article-title":"Economic evaluation of the home blood pressure telemonitoring and pharmacist case management to control hypertension (Hyperlink) trial. Article","volume":"1","author":"Dehmer","year":"2018","journal-title":"JACCP Journal of the American College of Clinical Pharmacy"},{"issue":"1","key":"10.1016\/j.sapharm.2024.01.002_bib31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11096-007-9134-y","article-title":"The cost effectiveness of a telephone-based pharmacy advisory service to improve adherence to newly prescribed medicines","volume":"30","author":"Elliott","year":"2008","journal-title":"Article. Pharmacy World and Science"},{"issue":"9","key":"10.1016\/j.sapharm.2024.01.002_bib32","first-page":"709","article-title":"Improving BP control through electronic communications: an economic evaluation","volume":"19","author":"Fishman","year":"2013","journal-title":"Am J Manag Care"},{"issue":"5","key":"10.1016\/j.sapharm.2024.01.002_bib33","first-page":"399","article-title":"Teleconsultation for the pharmaceutical care of HIV outpatients in receipt of home antiretrovirals delivery: clinical, economic, and patient-perceived quality analysis","volume":"25","author":"Margusino-Frami\u00f1\u00e1n","year":"2019","journal-title":"Article. Telemedicine journal and e-health : the official journal of the American Telemedicine Association"},{"issue":"2","key":"10.1016\/j.sapharm.2024.01.002_bib34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/jch.13459","article-title":"Cost-effectiveness of home blood pressure telemonitoring and case management in the secondary prevention of cerebrovascular disease in Canada. Article","volume":"21","author":"Padwal","year":"2019","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.sapharm.2024.01.002_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijchy.2020.100051","article-title":"Telemedicine can revolutionize the treatment of chronic disease","volume":"7","author":"Corbett","year":"2020","journal-title":"Int J Cardiol Hypertens"},{"issue":"6","key":"10.1016\/j.sapharm.2024.01.002_bib36","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jval.2021.12.001","article-title":"Economic evaluations of remote patient monitoring for chronic disease: a systematic review","volume":"25","author":"De Guzman","year":"2022","journal-title":"Value Health"},{"issue":"14","key":"10.1016\/j.sapharm.2024.01.002_bib37","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/jama.1996.03540140060028","article-title":"The role of cost-effectiveness analysis in health and medicine","volume":"276","author":"Russell","year":"1996","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.sapharm.2024.01.002_bib38","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/imj.15504","article-title":"Pharmacists reducing medication risk in medical outpatient clinics: a retrospective study of 18 clinics","volume":"53","author":"Snoswell","year":"2023","journal-title":"Intern Med J"},{"key":"10.1016\/j.sapharm.2024.01.002_bib39","series-title":"Cost-effectiveness in Health and Medicine","author":"Neumann","year":"2016"},{"issue":"1","key":"10.1016\/j.sapharm.2024.01.002_bib40","first-page":"55","article-title":"The limits of cost-effectiveness analysis","volume":"2","author":"Weintraub","year":"2009","journal-title":"Circulation: Cardiovascular Quality and Outcomes"},{"issue":"3","key":"10.1016\/j.sapharm.2024.01.002_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(16)00060-6","article-title":"Resisting the use of antibiotics for viral infections","volume":"4","author":"Tanday","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.sapharm.2024.01.002_bib42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.scitotenv.2019.04.231","article-title":"Improving performance of a pharmacy in a Romanian hospital through implementation of an internal management control system","volume":"675","author":"Daina","year":"2019","journal-title":"Sci Total Environ"},{"issue":"7","key":"10.1016\/j.sapharm.2024.01.002_bib43","article-title":"Telepharmacy services: present status and future perspectives: a review","volume":"55","author":"Baldoni","year":"2019","journal-title":"Medicina (Kaunas)"},{"issue":"9","key":"10.1016\/j.sapharm.2024.01.002_bib44","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/pds.1238","article-title":"Interview of patients by pharmacists contributes significantly to the identification of drug-related problems (DRPs)","volume":"15","author":"Viktil","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"10.1016\/j.sapharm.2024.01.002_bib45","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/archinternmed.2009.71","article-title":"A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial","volume":"169","author":"Gillespie","year":"2009","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.sapharm.2024.01.002_bib46","first-page":"533","article-title":"Opportunities and responsibilities in pharmaceutical care","volume":"47","author":"Hepler","year":"1990","journal-title":"American Journal of Hospital Pharmacy"},{"key":"10.1016\/j.sapharm.2024.01.002_bib47","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2147\/PPA.S191482","article-title":"Pharmacist-led medication non-adherence intervention: reducing the economic burden placed on the Australian health care system","volume":"13","author":"Cutler","year":"2019","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"10.1016\/j.sapharm.2024.01.002_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016982","article-title":"Economic impact of medication non-adherence by disease groups: a systematic review","volume":"8","author":"Cutler","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.sapharm.2024.01.002_bib49","article-title":"Interventions for enhancing medication adherence","volume":"11","author":"Nieuwlaat","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"21","key":"10.1016\/j.sapharm.2024.01.002_bib50","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1001\/jama.296.21.joc60162","article-title":"Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial","volume":"296","author":"Lee","year":"2006","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.sapharm.2024.01.002_bib51","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1081-1206(10)62557-4","article-title":"Measurement of children's asthma medication adherence by self report, mother report, canister weight, and Doser CT","volume":"85","author":"Bender","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.sapharm.2024.01.002_bib52","doi-asserted-by":"crossref","DOI":"10.2196\/19264","article-title":"Telehealth in the context of COVID-19: changing perspectives in Australia, the United Kingdom, and the United States","volume":"22","author":"Fisk","year":"2020","journal-title":"J Med Internet Res"},{"issue":"10","key":"10.1016\/j.sapharm.2024.01.002_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0275627","article-title":"Perspectives of clinical pharmacists on the provision of pharmaceutical care through telepharmacy services during COVID-19 pandemic in Qatar: a focus group","volume":"17","author":"Alhmoud","year":"2022","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.sapharm.2024.01.002_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.851","article-title":"Rapid implementation of telepharmacy service to improve patient-centric care and multidisciplinary collaboration across hospitals in a COVID era: a cross-sectional qualitative study","volume":"5","author":"Khoshnam-Rad","year":"2022","journal-title":"Health Sci Rep"},{"issue":"2","key":"10.1016\/j.sapharm.2024.01.002_bib55","first-page":"2634","article-title":"The rise of telepharmacy services during the COVID-19 pandemic: a comprehensive assessment of services in the United Arab Emirates","volume":"20","author":"Jirjees","year":"2022","journal-title":"Pharm Pract"},{"issue":"5","key":"10.1016\/j.sapharm.2024.01.002_bib56","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/1357633X20916567","article-title":"Telehealth for global emergencies: implications for coronavirus disease 2019 (COVID-19)","volume":"26","author":"Smith","year":"2020","journal-title":"J Telemed Telecare"},{"key":"10.1016\/j.sapharm.2024.01.002_bib57","first-page":"9","article-title":"How Australian health care services adapted to telehealth during the COVID-19 pandemic: a survey of telehealth professionals. Original research","author":"Taylor","year":"2021","journal-title":"Front Public Health"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741124000147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741124000147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:31:38Z","timestamp":1761557498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741124000147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1551741124000147"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2024.01.002","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic evaluations of telepharmacy services in non-cancer settings: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2024.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}